Carrillo ER, Carrillo CJR, Carrillo CLD

Idioma: Ingles.
Referencias bibliográficas: 9
Paginas: 144-145
Archivo PDF: 124.75 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. D’Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994; 14: 215-28.

2. Vauthey JN, Maddern GJ, Blumgart LH. Adult polycystic disease of the liver. Br J Surg 1991; 78: 524-7.

3. Levine E, Cook LT, Grantham JJ. Liver cysts in autosomal-dominant polycystic kidney disease: Clinical and computed tomographic study. Am J Roentgenol 1985; 145: 229-33.

4. Ramos A, Torres VE, Holley KE, Offord KP, Rakela J, Ludwig J. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114: 180-84.

5. Patterson M, Gonzalez-Vitale JC, Fagan CJ. Polycystic liver disease: A study of cyst fluid constituents. Hepatology 1982; 2: 475-8.

6. Alvaro D, Gigliozzi A, Attili AF. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 2000; 33: 333-40.

7. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-9.

8. Li TJ, Zhang HB, Lu JH, Zhao J, Yang N, Yang GS. Treatment of polycystic liver disease with resection-fenestration and a new classification. World J Gastroenterol 2008; 14: 5066-72.

9. Van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008; 57:1338-9.